publication venue for Single-agent gemcitabine in the treatment of advanced breast cancer. 4. 2004 Neoadjuvant docetaxel augments the efficacy of preoperative docetaxel/cyclophosphamide in operable breast cancer: First results of NSABP B-27. 2. 2002
